Capiton AG has successfully transitioned its investment in Dec Group to capiton VI, facilitating the company’s growth strategy and securing a partnership with financial investor ICG.

Target Information

Dec Group is a renowned global leader in high-containment processing technologies serving the pharmaceutical, chemical, and specialty industries. The company has undergone significant transformation and growth since capiton V's initial investment in 2020. With a commitment to providing comprehensive end-to-end solutions, Dec Group has successfully strengthened its market position through strategic acquisitions and an expanded product and technology portfolio, ultimately enhancing its value proposition.

Under capiton's stewardship, Dec Group evolved into a more competitive player in its sector, demonstrating remarkable resilience and adaptability. This transformation has not only positioned Dec to meet the existing demands of its industries but also to anticipate and capitalize on future trends, further solidifying its reputation as a trusted partner for blue-chip clients across more than 60 countries.

Industry Overview

The high-containment processing technology industry is experiencing significant growth, particularly as demand increases for advanced pharmaceutical and chemical solutions worldwide. Driven by r

View Source

Similar Deals

MDG Molecular Diagnostics Group GmbH oncgnostics GmbH

2025

Other Private Equity In-Vivo Diagnostic & Testing Substances Germany
SHS Capital Ackermann Instrumente GmbH

2025

Other Private Equity Medical Devices & Implants Germany
Serafin Unternehmensgruppe Gross GmbH

2025

Other Private Equity Hospitals, Clinics & Primary Care Services Germany
MEDICE – The Health Family Selfapy GmbH

2025

Other Private Equity Telemedicine Services Germany
Famar Group MiP Pharma

2025

Other Private Equity Generic Pharmaceuticals Germany
Gerresheimer AG Bormioli Pharma Group

2024

Other Private Equity Pharmaceuticals (NEC) Germany

capiton VI

invested in

Dec Group

in 2025

in a Other Private Equity deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert